<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mastitis and breast abscess in children and adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mastitis and breast abscess in children and adolescents</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mastitis and breast abscess in children and adolescents</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Chantay Banikarim, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nirupama K De Silva, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elise DeVore Berlan, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H980120578"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The clinical features, evaluation, and management of mastitis and breast abscess in children older than two months and adolescents will be discussed in this topic review. Mastitis and breast abscess in infants, lactational mastitis, and breast infections in adult women are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5974.html" rel="external">"Mastitis and breast abscess in infants younger than two months"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/798.html" rel="external">"Lactational mastitis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/794.html" rel="external">"Nonlactational mastitis in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/795.html" rel="external">"Primary breast abscess"</a>.)</p><p></p><p class="headingAnchor" id="H1603228245"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>In children and adolescents, mastitis is most commonly caused by <em>Staphylococcus aureus</em> but also may be caused by <em>Enterococcus</em>, <em>Streptococcus pyogenes</em> (group A <em>Streptococcus</em>), anaerobic streptococci, <em>Pseudomonas</em>, <em>Streptococcus agalactiae</em> (group B <em>Streptococcus</em>), and <em>Bacteroides </em>species [<a href="#rid1">1-3</a>]. Other unusual organisms such as <em>Actinomycosis</em> may be involved in patients whose infections are associated with nipple piercing [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/109.html" rel="external">"Body piercing in adolescents and young adults", section on 'Localized infection'</a>.)</p><p class="headingAnchor" id="H674772013"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Mastitis in children ≥2 years and adolescents results from the introduction of bacteria into the ductal system [<a href="#rid3">3</a>]. It is more likely at puberty or within a few months of menarche, when breast changes and growth are at a peak [<a href="#rid2">2,5</a>]. Factors that predispose to breast infection in children and nonlactating adolescents include superficial injury to the breast (eg, due to breast manipulation during sexual activity, shaving or plucking periareolar hair, picking acne lesions of the chest, nipple piercing, insect bites), obesity, mammary duct ectasia, hidradenitis suppurativa, local skin infection, and epidermoid cysts [<a href="#rid2">2,3,6-8</a>]. Peripheral mastitis may be associated with diabetes mellitus, rheumatoid arthritis, glucocorticoid therapy, granulomatous disease, and blunt trauma [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H1330254937"><span class="h1">CLINICAL FEATURES AND DIAGNOSIS</span><span class="headingEndMark"> — </span>Nonlactational mastitis is uncommon in children. After the first two months of life, it generally occurs in children ≥8 years of age [<a href="#rid1">1</a>].</p><p>The diagnosis of mastitis can be made clinically in children and adolescents with characteristic clinical features: swelling, erythema, warmth, tenderness, and induration of the central or peripheral breast [<a href="#rid1">1,8</a>]. Breast abscess is indicated by fluctuance  (<a class="graphic graphic_picture graphicRef76304" href="/d/graphic/76304.html" rel="external">picture 1</a>). Purulent nipple discharge also may be present.</p><p>Neither laboratory nor imaging studies are necessary to diagnose mastitis or breast abscess. We obtain the following studies as clinically indicated:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gram stain and cultures</strong> – We obtain Gram stain and culture of nipple discharge if present or abscess fluid in patients with breast abscess. Positive Gram stain and/or culture support the diagnosis and guide antimicrobial therapy. (See <a class="local">'Drainage of breast abscess'</a> below and <a class="local">'Antimicrobial therapy'</a> below.)</p><p></p><p class="bulletIndent1">We do not routinely obtain blood cultures in children and adolescents with mastitis or breast abscess unless they fail to respond to treatment. Blood cultures are of low yield unless the cellulitis is severe [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/110529.html" rel="external">"Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complete blood count with differential</strong> – We obtain complete blood count with differential in patients with fever, systemic symptoms, abscess or potential abscess, or recurrent mastitis. Leukocytosis supports the diagnosis and may be used to follow the clinical course; measurement of other inflammatory markers (eg, erythrocyte sedimentation rate and C-reactive protein) usually is not necessary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ultrasound imaging </strong>– Although ultrasonography is not necessary for the diagnosis of breast abscess, we use it to guide therapeutic and diagnostic needle aspiration. Ultrasound findings of breast abscess include irregular shape with ill-defined margins, a complex hypoechoic center, and thick echogenic wall [<a href="#rid10">10</a>].</p><p></p><p class="headingAnchor" id="H3028345914"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The major consideration in the differential diagnosis of mastitis or breast abscess in children and adolescents is breast trauma. Trauma to the breast (eg, direct blows to the breast, seatbelt injury) may result in hematomas or fat necrosis, which can resemble a solid mass [<a href="#rid2">2,8,11</a>]. The solid mass distinguishes fat necrosis from mastitis (in which there is no distinct mass) and breast abscess (in which the mass is fluctuant). Breast ultrasonography may help to differentiate mastitis and breast abscess from sequelae of trauma [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/104.html" rel="external">"Breast masses in children and adolescents", section on 'Breast trauma'</a>.)</p><p>Conditions that infrequently mimic mastitis or breast abscess in older children and adolescents include [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphangioma – Lymphangiomas (eg, cystic hygromas) are malformations of the lymphatic system that are characterized by thin walled cysts; they rarely occur in the breast [<a href="#rid13">13,14</a>]. The absences of erythema, tenderness, and warmth distinguish lymphangioma from mastitis and breast abscess.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mammary duct ectasia (ie, distension of subareolar ducts with fibrosis and inflammation) – Mammary duct ectasia may be associated with a bloody or dark green-brown nipple discharge in children and adolescent [<a href="#rid15">15</a>]. It also may predispose to infection. Ultrasonography demonstrates retroareolar, dilated, anechoic tubular structures, possibly with echogenic debris [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/104.html" rel="external">"Breast masses in children and adolescents", section on 'Mammary duct ectasia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Superficial thrombophlebitis of the thoracoepigastric vein (Mondor disease) – Clinical features that distinguish superficial thrombophlebitis of the thoracoepigastric vein from mastitis or breast abscess include a thickened tender cord that is painful, erythematous, and swollen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Carcinoma – Breast cancer is exceedingly rare in adolescents. The most common finding of breast cancer in adolescents is a hard, irregular mass, which may or may not be fixed to the underlying tissue. The hardness of the mass distinguishes carcinoma from mastitis, in which there is no distinct mass, and breast abscess, which is typically fluctuant. (See  <a class="medical medical_review" href="/d/html/104.html" rel="external">"Breast masses in children and adolescents", section on 'Breast cancer'</a>.)</p><p></p><p class="headingAnchor" id="H2994584853"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Management of mastitis and breast abscess consists of supportive care, antimicrobial therapy, and drainage (if there is a drainable abscess).</p><p class="headingAnchor" id="H3500134123"><span class="h2">Supportive care</span><span class="headingEndMark"> — </span>Supportive care for children and adolescents with mastitis includes application of warm compresses and provision of breast support (as necessary) [<a href="#rid3">3,7</a>].</p><p class="headingAnchor" id="H3596652047"><span class="h2">Antimicrobial therapy</span></p><p class="headingAnchor" id="H3576843133"><span class="h3">Choice of regimen</span><span class="headingEndMark"> — </span>No randomized controlled trials have evaluated antibiotic regimens for mastitis in older children and adolescents. Recommendations for treatment are based upon the most likely causative pathogens and response to therapy described in observational studies [<a href="#rid1">1,6</a>].</p><p>The choice of antibiotics is guided by the Gram stain if one is available and a pathogenic organism is identified (eg, antistaphylococcal therapy for gram-positive cocci in clusters). If a Gram stain is not available, we provide empiric coverage for <em>S. aureus </em>and group A <em>Streptococcus</em> (GAS) [<a href="#rid2">2,7</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immune competent, well-appearing, and no systemic symptoms</strong> – For immune-competent children and adolescents with mastitis or breast abscess who are well appearing and without systemic symptoms, we use oral antimicrobial therapy  (<a class="graphic graphic_table graphicRef111071" href="/d/graphic/111071.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1">Appropriate empiric oral regimens include monotherapy with one of the following [<a href="#rid16">16</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="13138" href="/d/drug information/13138.html" rel="external">Cephalexin</a> 25 to 50 mg/kg per day orally in three or four doses (maximum daily dose: 2 g)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">Clindamycin</a> 30 to 40 mg/kg per day orally in three or four doses (maximum daily dose: 1.8 g)</p><p></p><p class="bulletIndent2"><a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">Clindamycin</a> is suggested in areas with increased incidence of community-associated methicillin-resistant <em>S. aureus</em> (CA-MRSA; more than 10 percent of community isolates)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9288" href="/d/drug information/9288.html" rel="external">Cloxacillin</a> (not available in the United States) 25 to 50 mg/kg per day orally in four doses (maximum daily dose: 2 g)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="13227" href="/d/drug information/13227.html" rel="external">Dicloxacillin</a> 25 to 50 mg/kg per day orally in four doses (maximum daily dose: 2 g)</p><p></p><p class="bulletIndent1"><a class="drug drug_pediatric" data-topicid="12816" href="/d/drug information/12816.html" rel="external">Trimethoprim-sulfamethoxazole</a> (TMP-SMX) 8 to 12 mg TMP/kg per day orally in two doses (maximum daily dose of TMP component: 320 mg) is another alternative in areas with an increased incidence of CA-MRSA. However, TMP-SMX is not active against GAS.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ill-appearance, systemic symptoms, rapid progression, or immune compromise</strong> – For children and adolescents with mastitis or breast abscess who are ill appearing, have systemic symptoms, have rapid progression of erythema, or are immunocompromised, we begin treatment parenterally. Patients may be transitioned from parenteral to oral therapy when fever and systemic symptoms have resolved and localized findings have improved.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CA-MRSA not a concern</strong> – Appropriate empiric parenteral regimens if CA-MRSA is not a concern include monotherapy with one of the following [<a href="#rid16">16</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="13124" href="/d/drug information/13124.html" rel="external">Cefazolin</a> 50 to 100 mg/kg per day intravenously (IV) in three doses (maximum daily dose: 3 g)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="12626" href="/d/drug information/12626.html" rel="external">Nafcillin</a> 150 to 200 mg/kg per day IV in four to six doses (maximum daily dose: 12 g)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="12663" href="/d/drug information/12663.html" rel="external">Oxacillin</a> 150 to 200 mg/kg per day IV in four to six doses (maximum daily dose: 12 g)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CA-MRSA a concern or life-threatening penicillin allergy</strong> – Appropriate parenteral regimens if CA-MRSA is a concern or the patient has a life-threatening penicillin allergy include [<a href="#rid16">16</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">Clindamycin</a> 30 to 40 mg/kg per day IV in three or four doses (maximum daily dose 2.7 g)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="12874" href="/d/drug information/12874.html" rel="external">Vancomycin</a>  (<a class="graphic graphic_table graphicRef129344" href="/d/graphic/129344.html" rel="external">table 2</a>)</p><p></p><p class="bulletIndent2">(See  <a class="medical medical_review" href="/d/html/2073.html" rel="external">"Penicillin allergy: Immediate reactions"</a> and  <a class="medical medical_review" href="/d/html/2087.html" rel="external">"Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics"</a>.)</p><p></p><p>Our recommendations for antimicrobial therapy are generally consistent with the 2014 Infectious Diseases Society of America guidelines on the diagnosis and management of skin and soft-tissue infections [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H1600681885"><span class="h3">Duration of therapy</span><span class="headingEndMark"> — </span>The total duration of systemic antimicrobial therapy for mastitis and breast abscess is not well studied. It depends upon the type of infection and clinical response. We generally treat for 7 to 10 days and extend or adjust the course if the infection has not improved within 10 days. However, a minimum duration of five days may be adequate provided the patient improves clinically and the course is uncomplicated [<a href="#rid16">16</a>]. (See <a class="local">'Failure to respond'</a> below.)</p><p class="headingAnchor" id="H3908938302"><span class="h2">Drainage of breast abscess</span><span class="headingEndMark"> — </span>In addition to antimicrobial therapy, breast abscess may require ultrasound-guided fine needle aspiration or incision and drainage if there is no response to antimicrobial therapy [<a href="#rid8">8,17</a>].</p><p>During drainage, care must be taken to avoid the breast bud in prepubertal/pubertal children [<a href="#rid3">3,17</a>]. If incision and drainage is necessary, it should be performed by appropriately trained personnel (eg, a breast surgeon, pediatric surgeon, or breast radiologist) to minimize the risk of hypoplasia or scarring.</p><p class="headingAnchor" id="H4264467744"><span class="h1">RESPONSE TO THERAPY</span></p><p class="headingAnchor" id="H2396839029"><span class="h2">Monitoring response</span><span class="headingEndMark"> — </span>Response to therapy is indicated by clinical improvement within 24 to 48 hours of appropriate antibiotic therapy. As with all soft tissue infections, use of a marking pen to outline the erythematous area allows the clinician to assess the patient's response to therapy. Rapid progression of erythema supports use of parenteral antibiotics or need to reassess choice of antibiotics.</p><p class="headingAnchor" id="H649101927"><span class="h2">Failure to respond</span><span class="headingEndMark"> — </span>Possible explanations for failure to respond to empiric or directed antimicrobial therapy within 24 to 48 hours include [<a href="#rid8">8,17</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Resistance to initial antibiotic</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inadequate concentration of antibiotic (eg, if administered orally)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inadequate abscess drainage (if drainage was performed), recurrent abscess, or development of a new abscess</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Incorrect diagnoses (see <a class="local">'Differential diagnosis'</a> above)</p><p></p><p>Ultrasonography may identify residual, recurrent, or new abscesses that require drainage, particularly if induration makes it difficult to assess fluctuance. Ultrasonography can also be used to guide the drainage procedure if drainage is necessary.</p><p>For patients in whom cultures were not obtained or in whom cultures remain negative, a resistant pathogen is another possible explanation for treatment failure. In such patients, it may be necessary to broaden empiric antimicrobial therapy to include activity against resistant pathogens not addressed in the initial regimen (eg, switching from <a class="drug drug_pediatric" data-topicid="13138" href="/d/drug information/13138.html" rel="external">cephalexin</a> to <a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">clindamycin</a> if methicillin-resistant <em>S. aureus</em> is a concern, adding coverage for less frequent pathogens) or to switch from oral to parenteral therapy.</p><p class="headingAnchor" id="H1248462384"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Most children and adolescents with mastitis or breast abscess recover without physical sequelae. Patients with <em>S. aureus</em> mastitis are at risk for subsequent <em>S. aureus</em> infections at other sites. (See  <a class="medical medical_review" href="/d/html/6065.html" rel="external">"Methicillin-resistant <i>Staphylococcus aureus </i>infections in children: Epidemiology and clinical spectrum"</a>.)</p><p class="headingAnchor" id="H2117410213"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110086.html" rel="external">"Society guideline links: Skin and soft tissue infections"</a>.)</p><p class="headingAnchor" id="H999630592"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology </strong>–<em> Staphylococcus aureus</em> is the most frequent cause of breast infection in children and adolescents. Other causes include <em>Enterococcus</em>, group A <em>Streptococcus</em> (GAS), anaerobic streptococci, <em>Pseudomonas</em>, group B <em>Streptococcus</em>, and <em>Bacteroides </em>species. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features and diagnosis</strong> – A clinical diagnosis of mastitis and/or breast abscess can be made in patients with swelling, erythema, warmth, tenderness, induration, and/or fluctuance of the breast. Isolation of a pathogen on Gram stain or culture of purulent nipple drainage or abscess fluid (if present) support the diagnosis and direct antimicrobial therapy. (See <a class="local">'Clinical features and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antimicrobial therapy</strong> – Initial antimicrobial therapy is based upon the Gram stain if one is available and a pathogenic organism is identified. If Gram stain is not available, we provide empiric coverage for <em>S. aureus</em> and GAS. (See <a class="local">'Antimicrobial therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For immune-competent children and adolescents with mastitis or breast abscess who are well appearing and without systemic symptoms, we initiate antimicrobial therapy orally. Appropriate oral empiric agents include <a class="drug drug_pediatric" data-topicid="13227" href="/d/drug information/13227.html" rel="external">dicloxacillin</a>, <a class="drug drug_general" data-topicid="9288" href="/d/drug information/9288.html" rel="external">cloxacillin</a> (not available in the United States), <a class="drug drug_pediatric" data-topicid="13138" href="/d/drug information/13138.html" rel="external">cephalexin</a>, and <a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">clindamycin</a>  (<a class="graphic graphic_table graphicRef111071" href="/d/graphic/111071.html" rel="external">table 1</a>). Clindamycin may be necessary in areas with increased incidence of community-associated methicillin-resistant <em>S. aureus </em>(CA-MRSA). <a class="drug drug_pediatric" data-topicid="12816" href="/d/drug information/12816.html" rel="external">Trimethoprim-sulfamethoxazole</a> is another alternative for areas with increased incidence of CA-MRSA, but it does not provide adequate coverage for GAS.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For children and adolescents with mastitis or breast abscess who are ill appearing, have systemic symptoms, have rapid progression of erythema, or are immunocompromised, we initiate antimicrobial therapy parenterally. Appropriate parenteral empiric agents include <a class="drug drug_pediatric" data-topicid="13124" href="/d/drug information/13124.html" rel="external">cefazolin</a>, <a class="drug drug_pediatric" data-topicid="12626" href="/d/drug information/12626.html" rel="external">nafcillin</a>, or <a class="drug drug_pediatric" data-topicid="12663" href="/d/drug information/12663.html" rel="external">oxacillin</a> if CA-MRSA is not a concern and <a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">clindamycin</a> or <a class="drug drug_pediatric" data-topicid="12874" href="/d/drug information/12874.html" rel="external">vancomycin</a> if CA-MRSA is a concern  (<a class="graphic graphic_table graphicRef111071" href="/d/graphic/111071.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1">We generally treat mastitis or breast abscess in children and adolescents with antimicrobial therapy for 7 to 10 days and extend or adjust the course if the infection has not improved within 10 days. (See <a class="local">'Duration of therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drainage of breast abscess</strong> – Breast abscess may require ultrasound-guided needle aspiration to direct antibiotic management or incision and drainage in addition to antimicrobial therapy if there is no response to antimicrobial therapy. Incision and drainage should be performed by appropriately trained personnel (eg, a breast surgeon, pediatric surgeon, or breast radiologist). (See <a class="local">'Drainage of breast abscess'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Response to therapy</strong> – Response to therapy is indicated by clinical improvement within 24 to 48 hours of appropriate antibiotic therapy. Failure to respond to antimicrobial therapy may indicate a resistant pathogen, inadequate concentration of antibiotic, abscess (residual, recurrent, or new), or incorrect diagnosis. (See <a class="local">'Response to therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – Most patients with mastitis or breast abscess recover without sequelae. Patients with <em>S. aureus</em> mastitis are at risk for subsequent <em>S. aureus</em> infections at other sites. (See <a class="local">'Prognosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Faden H. Mastitis in children from birth to 17 years. Pediatr Infect Dis J 2005; 24:1113.</a></li><li><a class="nounderline abstract_t">Greydanus DE, Matytsina L, Gains M. Breast disorders in children and adolescents. Prim Care 2006; 33:455.</a></li><li class="breakAll">Baren JM. Breast lesions. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams and Wilkins, Philadelphia 2006. p.193.</li><li><a class="nounderline abstract_t">Warren R, Degnim AC. Uncommon benign breast abnormalities in adolescents. Semin Plast Surg 2013; 27:26.</a></li><li><a class="nounderline abstract_t">Michala L, Tsigginou A, Zacharakis D, Dimitrakakis C. Breast disorders in girls and adolescents. Is there a need for a specialized service? J Pediatr Adolesc Gynecol 2015; 28:91.</a></li><li><a class="nounderline abstract_t">Stricker T, Navratil F, Forster I, et al. Nonpuerperal mastitis in adolescents. J Pediatr 2006; 148:278.</a></li><li><a class="nounderline abstract_t">Templeman C, Hertweck SP. Breast disorders in the pediatric and adolescent patient. Obstet Gynecol Clin North Am 2000; 27:19.</a></li><li class="breakAll">DiVasta AD, Weldon CB, Labow BI. The breast: Examination and lesions. In: Emans, Laufer, Goldstein's Pediatric &amp; Adolescent Gynecology, 7th ed, Emans SJ, Laufer MR, DiVasta AD (Eds), Wolters Kluwer, Philadelphia 2020. p.781.</li><li><a class="nounderline abstract_t">Perl B, Gottehrer NP, Raveh D, et al. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 1999; 29:1483.</a></li><li><a class="nounderline abstract_t">Valeur NS, Rahbar H, Chapman T. Ultrasound of pediatric breast masses: what to do with lumps and bumps. Pediatr Radiol 2015; 45:1584.</a></li><li><a class="nounderline abstract_t">Williams HJ, Hejmadi RK, England DW, Bradley SA. Imaging features of breast trauma: a pictorial review. Breast 2002; 11:107.</a></li><li><a class="nounderline abstract_t">Schwartz GF. Benign neoplasms and "inflammations" of the breast. Clin Obstet Gynecol 1982; 25:373.</a></li><li><a class="nounderline abstract_t">Ekmez F, Pirgon O, Bilgin H, Aydemir G. Cystic hygroma of the breast in a 5 year old boy presenting as a gynecomastia. Eur Rev Med Pharmacol Sci 2012; 16 Suppl 4:55.</a></li><li><a class="nounderline abstract_t">Kangesu T. Cystic hygroma of the breast in childhood. Br J Clin Pract 1990; 44:787.</a></li><li><a class="nounderline abstract_t">McHoney M, Munro F, Mackinlay G. Mammary duct ectasia in children: report of a short series and review of the literature. Early Hum Dev 2011; 87:527.</a></li><li><a class="nounderline abstract_t">Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014; 59:147.</a></li><li><a class="nounderline abstract_t">Schwarz RJ, Shrestha R. Needle aspiration of breast abscesses. Am J Surg 2001; 182:117.</a></li></ol></div><div id="topicVersionRevision">Topic 110660 Version 11.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371879" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Mastitis in children from birth to 17 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16713771" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Breast disorders in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16713771" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Breast disorders in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24872736" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Uncommon benign breast abnormalities in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25850589" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Breast disorders in girls and adolescents. Is there a need for a specialized service?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16492444" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Nonpuerperal mastitis in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10693180" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Breast disorders in the pediatric and adolescent patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10693180" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Breast disorders in the pediatric and adolescent patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10585800" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cost-effectiveness of blood cultures for adult patients with cellulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26164440" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ultrasound of pediatric breast masses: what to do with lumps and bumps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14965655" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Imaging features of breast trauma: a pictorial review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6286199" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Benign neoplasms and "inflammations" of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23090809" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Cystic hygroma of the breast in a 5 year old boy presenting as a gynecomastia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2102250" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cystic hygroma of the breast in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21550735" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Mammary duct ectasia in children: report of a short series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24947530" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11574080" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Needle aspiration of breast abscesses.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
